These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 36623814)

  • 1. Inflammatory bowel disease-associated intestinal fibrosis.
    Park JM; Kim J; Lee YJ; Bae SU; Lee HW
    J Pathol Transl Med; 2023 Jan; 57(1):60-66. PubMed ID: 36623814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease.
    Lovisa S; Genovese G; Danese S
    J Crohns Colitis; 2019 Apr; 13(5):659-668. PubMed ID: 30520951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the epithelial barrier in intestinal fibrosis associated with inflammatory bowel disease: relevance of the epithelial-to mesenchymal transition.
    Macias-Ceja DC; Mendoza-Ballesteros MT; Ortega-Albiach M; Barrachina MD; Ortiz-Masià D
    Front Cell Dev Biol; 2023; 11():1258843. PubMed ID: 37822869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventing fibrosis in IBD: update on immune pathways and clinical strategies.
    Wang J; Yang B; Chandra J; Ivanov A; Brown JM; Rieder F
    Expert Rev Clin Immunol; 2024 Jul; 20(7):727-734. PubMed ID: 38475672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of initiation and progression of intestinal fibrosis in IBD.
    Latella G; Di Gregorio J; Flati V; Rieder F; Lawrance IC
    Scand J Gastroenterol; 2015 Jan; 50(1):53-65. PubMed ID: 25523556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
    Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
    Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains.
    Bosselaar S; Dhelin L; Dautel E; Titecat M; Duthoy S; Stelmaszczyk M; Delory N; De Sousa Violante M; Machuron F; Ait-Abderrahim H; Desreumaux P; Foligné B; Monnet C
    BMC Microbiol; 2024 Jun; 24(1):233. PubMed ID: 38951788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
    Hashash JG; Elkins J; Lewis JD; Binion DG
    Gastroenterology; 2024 Mar; 166(3):521-532. PubMed ID: 38276922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting fibrosis in inflammatory bowel disease: the gut thickens.
    D'Alessio S; Ungaro F; Noviello D; Lovisa S; Peyrin-Biroulet L; Danese S
    Nat Rev Gastroenterol Hepatol; 2022 Mar; 19(3):169-184. PubMed ID: 34876680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bowel stiffness associated with histopathologic scoring of stenosis in patients with Crohn's disease.
    Zhao J; Liao D; Wilkens R; Krogh K; Glerup H; Gregersen H
    Acta Biomater; 2021 Aug; 130():332-342. PubMed ID: 34119715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Inflammatory Bowel Disease in Canada 2018: Extra-intestinal Diseases in IBD.
    Bernstein CN; Benchimol EI; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Kaplan GG
    J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S73-S80. PubMed ID: 31294387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.
    Bamias G; Pizarro TT; Cominelli F
    Inflamm Bowel Dis; 2022 Mar; 28(3):337-349. PubMed ID: 34904152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A galectin-specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disorders.
    Papa Gobbi R; De Francesco N; Bondar C; Muglia C; Chirdo F; Rumbo M; Rocca A; Toscano MA; Sambuelli A; Rabinovich GA; Docena GH
    Biofactors; 2016; 42(1):93-105. PubMed ID: 26891020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut Microbial Metabolite Butyrate and Its Therapeutic Role in Inflammatory Bowel Disease: A Literature Review.
    Recharla N; Geesala R; Shi XZ
    Nutrients; 2023 May; 15(10):. PubMed ID: 37242159
    [No Abstract]   [Full Text] [Related]  

  • 16. Betulinic acid hydroxamate prevents colonic inflammation and fibrosis in murine models of inflammatory bowel disease.
    Prados ME; García-Martín A; Unciti-Broceta JD; Palomares B; Collado JA; Minassi A; Calzado MA; Appendino G; Muñoz E
    Acta Pharmacol Sin; 2021 Jul; 42(7):1124-1138. PubMed ID: 32811965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrostenosing Crohn's Disease: Pathogenetic Mechanisms and New Therapeutic Horizons.
    Mignini I; Blasi V; Termite F; Esposto G; Borriello R; Laterza L; Scaldaferri F; Ainora ME; Gasbarrini A; Zocco MA
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of patient-derived intestinal organoids for modelling fibrosis in Inflammatory Bowel Disease.
    Laudadio I; Carissimi C; Scafa N; Bastianelli A; Fulci V; Renzini A; Russo G; Oliva S; Vitali R; Palone F; Cucchiara S; Stronati L
    Inflamm Res; 2024 Aug; 73(8):1359-1370. PubMed ID: 38842554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can we prevent, reduce or reverse intestinal fibrosis in IBD?
    Latella G; Sferra R; Speca S; Vetuschi A; Gaudio E
    Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1283-304. PubMed ID: 23740440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.